Digital Pathology in Cancer Medicine: Applications, Benefits, and Future Directions

Authors

  • Dr. Mehul Shah Associate Professor Faculty of Pharmacy, Central Health University, Ahmedabad, India Author
  • Dr. Poonam Yadav Professor Department of Clinical Pharmacy, Central Health University, Ahmedabad, India Author
  • Mr. Nishant Sinha Assistant Professor Department of Pharmaceutical Chemistry, Central Health University, Ahmedabad, India Author
  • Mr. Harish Kumar Associate Professor Department of Pharmacology, Western Health Sciences University, Pune, India Author
  • Mrs. Kavya Rao Professor Department of Pharmacy Practice, Western Health Sciences University, Pune, India Author
  • Dr. Deepak Mishra Associate Professor Department of Pharmacognosy, Western Health Sciences University, Pune, India. Author

Keywords:

Digital pathology, Cancer medicine, Computational pathology, Artificial intelligence, Whole-slide imaging, Precision oncology, Deep learning, Histopathology, Biomarkers, Precision medicine.

Abstract

Background: Digital pathology has emerged as one of the most transformative innovations in modern cancer medicine, fundamentally changing how pathological specimens are analyzed, interpreted, archived, and integrated into precision oncology. Traditional microscopy-based pathology has served as the gold standard for cancer diagnosis for more than a century; however, increasing cancer incidence, growingdiagnostic complexity, and the rapid expansion of molecular medicine have created substantial challenges related to workload, reproducibility, and diagnostic consistency. Digital pathology addresses these limitations by converting conventional glass slides into high-resolution whole-slide images that can be analyzed using advanced computational algorithms, artificial intelligence (AI), and deep learning technologies. The integration of digital pathology with radiology, genomics, transcriptomics, proteomics, and electronic health records has facilitated the development of comprehensive multimodal diagnostic platforms capable of improving tumor classification, biomarker identification, prognostic prediction, and therapeutic decision-making. Recent advances in machine learning, transformerbased architectures, computational image analysis, and foundation models have further accelerated the role of digital pathology in precision oncology by enabling automated tissue segmentation, molecular prediction, tumor microenvironment characterization, and prediction of treatment response. Digital pathology also supports remote diagnostics, telepathology, multidisciplinary collaboration, educational training, and large-scale research through efficient digital data sharing and centralized image repositories. Despite its remarkable advantages, challenges including image standardization, data storage requirements, algorithm interpretability, cybersecurity, regulatory approval, and integration into routine clinical workflows remain significant barriers to widespread implementation. This review provides a comprehensive overview of digital pathology technologies, clinical applications, advantages, current limitations, and future directions in cancer medicine while highlighting the expanding role of computational pathology in advancing personalized oncology and precision healthcare.

Downloads

Published

2026-06-20

How to Cite

Dr. Mehul Shah, Dr. Poonam Yadav, Mr. Nishant Sinha, Mr. Harish Kumar, Mrs. Kavya Rao, & Dr. Deepak Mishra. (2026). Digital Pathology in Cancer Medicine: Applications, Benefits, and Future Directions. International Journal of Multidisciplinary Research in Biotechnology, Pharmacy, Dental and Medical Sciences , 2(6), 11-20. https://ijmrbpdms.org/index.php/files/article/view/63